Related references
Note: Only part of the references are listed.FTY720 Inhibits Ceramide Synthases and Up-regulates Dihydrosphingosine 1-Phosphate Formation in Human Lung Endothelial Cells
Evgeny V. Berdyshev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Chiral Vinylphosphonate and Phosphonate Analogues of the Immunosuppressive Agent FTY720
Xuequan Lu et al.
JOURNAL OF ORGANIC CHEMISTRY (2009)
Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod
Veronique E. Miron et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720
Akio Kihara et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells
Yasuo Nagaoka et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCζ activation
Ana M. Sanchez et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
FTY720 (fingolimod) for relapsing multiple sclerosis
Alejandro Horga et al.
Expert Review of Neurotherapeutics (2008)
Characterization of ceramide synthase 2 - Tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate
Elad L. Laviad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Recent Trials for FTY720 (Fingolimod): A New Generation of Immunomodulators Structurally Similar to Sphingosine
Moizza Mansoor et al.
REVIEWS ON RECENT CLINICAL TRIALS (2008)
Kinetic characterization of mammalian ceramide synthases:: Determination of Km values towards sphinganine
Sujoy Lahiri et al.
FEBS LETTERS (2007)
Fingolimod: A novel immunosuppressant for multiple sclerosis
Brandon A. Brown et al.
ANNALS OF PHARMACOTHERAPY (2007)
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia
Paolo Neviani et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The immunosuppressant drug FTY720 inhibits cytosohc phospholipase A2 independently of sphingosine-1-phosphate receptors
Shawn G. Payne et al.
BLOOD (2007)
Sphingosine 1-phosphate receptor modulators: a new class of immunosuppressants
Adam C. Yopp et al.
CLINICAL TRANSPLANTATION (2006)
LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro)ceramide synthase with relatively broad substrate specificity
Yukiko Mizutani et al.
BIOCHEMICAL JOURNAL (2006)
Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses
Guy M. L. Meno-Tetang et al.
DRUG METABOLISM AND DISPOSITION (2006)
Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
B Zemann et al.
BLOOD (2006)
Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720
Y Kharel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity
P Bandhuvula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor
S Lahiri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sphingolipidomics: High-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry
AH Merrill et al.
METHODS (2005)
Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2
BJ Pettus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas
S Koybasi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases
A Billich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability
T Sanchez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors
C Riebeling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells
Y Matsuoka et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro)ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells
K Venkataraman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
V Brinkmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
S Mandala et al.
SCIENCE (2002)
Assessment of agonism at G-protein coupled receptors by phosphatidic acid and lysophosphatidic acid in human embryonic kidney 293 cells
F Alderton et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory
DD Pinschewer et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
